Conditionally reprogrammed normal and transformed mouse mammary epithelial cells display a progenitor-cell-like phenotype. 2014

Francisco R Saenz, and Virginie Ory, and Maram AlOtaiby, and Sonia Rosenfield, and Mary Furlong, and Luciane R Cavalli, and Michael D Johnson, and Xuefeng Liu, and Richard Schlegel, and Anton Wellstein, and Anna T Riegel
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, United States of America.

Mammary epithelial (ME) cells cultured under conventional conditions senesce after several passages. Here, we demonstrate that mouse ME cells isolated from normal mammary glands or from mouse mammary tumor virus (MMTV)-Neu-induced mammary tumors, can be cultured indefinitely as conditionally reprogrammed cells (CRCs) on irradiated fibroblasts in the presence of the Rho kinase inhibitor Y-27632. Cell surface progenitor-associated markers are rapidly induced in normal mouse ME-CRCs relative to ME cells. However, the expression of certain mammary progenitor subpopulations, such as CD49f+ ESA+ CD44+, drops significantly in later passages. Nevertheless, mouse ME-CRCs grown in a three-dimensional extracellular matrix gave rise to mammary acinar structures. ME-CRCs isolated from MMTV-Neu transgenic mouse mammary tumors express high levels of HER2/neu, as well as tumor-initiating cell markers, such as CD44+, CD49f+, and ESA+ (EpCam). These patterns of expression are sustained in later CRC passages. Early and late passage ME-CRCs from MMTV-Neu tumors that were implanted in the mammary fat pads of syngeneic or nude mice developed vascular tumors that metastasized within 6 weeks of transplantation. Importantly, the histopathology of these tumors was indistinguishable from that of the parental tumors that develop in the MMTV-Neu mice. Application of the CRC system to mouse mammary epithelial cells provides an attractive model system to study the genetics and phenotype of normal and transformed mouse epithelium in a defined culture environment and in vivo transplant studies.

UI MeSH Term Description Entries
D007797 Laminin Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cells to the basement membrane. Evidence suggests that the protein plays a role in tumor invasion. Merosin,Glycoprotein GP-2,Laminin M,Laminin M Chain,Chain, Laminin M,Glycoprotein GP 2,M Chain, Laminin
D008321 Mammary Glands, Animal MAMMARY GLANDS in the non-human MAMMALS. Mammae,Udder,Animal Mammary Glands,Animal Mammary Gland,Mammary Gland, Animal,Udders
D008324 Mammary Tumor Virus, Mouse The type species of BETARETROVIRUS commonly latent in mice. It causes mammary adenocarcinoma in a genetically susceptible strain of mice when the appropriate hormonal influences operate. Bittner Virus,Mammary Cancer Virus,Mouse mammary tumor virus,Mammary Tumor Viruses, Mouse
D008325 Mammary Neoplasms, Experimental Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS. Experimental Mammary Neoplasms,Neoplasms, Experimental Mammary,Experimental Mammary Neoplasm,Mammary Neoplasm, Experimental,Neoplasm, Experimental Mammary
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011509 Proteoglycans Glycoproteins which have a very high polysaccharide content. Proteoglycan,Proteoglycan Type H
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell

Related Publications

Francisco R Saenz, and Virginie Ory, and Maram AlOtaiby, and Sonia Rosenfield, and Mary Furlong, and Luciane R Cavalli, and Michael D Johnson, and Xuefeng Liu, and Richard Schlegel, and Anton Wellstein, and Anna T Riegel
December 2012, Proceedings of the National Academy of Sciences of the United States of America,
Francisco R Saenz, and Virginie Ory, and Maram AlOtaiby, and Sonia Rosenfield, and Mary Furlong, and Luciane R Cavalli, and Michael D Johnson, and Xuefeng Liu, and Richard Schlegel, and Anton Wellstein, and Anna T Riegel
April 2018, Tissue engineering. Part A,
Francisco R Saenz, and Virginie Ory, and Maram AlOtaiby, and Sonia Rosenfield, and Mary Furlong, and Luciane R Cavalli, and Michael D Johnson, and Xuefeng Liu, and Richard Schlegel, and Anton Wellstein, and Anna T Riegel
April 1987, Journal of the National Cancer Institute,
Francisco R Saenz, and Virginie Ory, and Maram AlOtaiby, and Sonia Rosenfield, and Mary Furlong, and Luciane R Cavalli, and Michael D Johnson, and Xuefeng Liu, and Richard Schlegel, and Anton Wellstein, and Anna T Riegel
June 2020, Virologica Sinica,
Francisco R Saenz, and Virginie Ory, and Maram AlOtaiby, and Sonia Rosenfield, and Mary Furlong, and Luciane R Cavalli, and Michael D Johnson, and Xuefeng Liu, and Richard Schlegel, and Anton Wellstein, and Anna T Riegel
February 2011, Oncogene,
Francisco R Saenz, and Virginie Ory, and Maram AlOtaiby, and Sonia Rosenfield, and Mary Furlong, and Luciane R Cavalli, and Michael D Johnson, and Xuefeng Liu, and Richard Schlegel, and Anton Wellstein, and Anna T Riegel
September 1981, Journal of the National Cancer Institute,
Francisco R Saenz, and Virginie Ory, and Maram AlOtaiby, and Sonia Rosenfield, and Mary Furlong, and Luciane R Cavalli, and Michael D Johnson, and Xuefeng Liu, and Richard Schlegel, and Anton Wellstein, and Anna T Riegel
May 2022, Stem cell research & therapy,
Francisco R Saenz, and Virginie Ory, and Maram AlOtaiby, and Sonia Rosenfield, and Mary Furlong, and Luciane R Cavalli, and Michael D Johnson, and Xuefeng Liu, and Richard Schlegel, and Anton Wellstein, and Anna T Riegel
May 2017, American journal of respiratory cell and molecular biology,
Francisco R Saenz, and Virginie Ory, and Maram AlOtaiby, and Sonia Rosenfield, and Mary Furlong, and Luciane R Cavalli, and Michael D Johnson, and Xuefeng Liu, and Richard Schlegel, and Anton Wellstein, and Anna T Riegel
April 2017, Oncotarget,
Francisco R Saenz, and Virginie Ory, and Maram AlOtaiby, and Sonia Rosenfield, and Mary Furlong, and Luciane R Cavalli, and Michael D Johnson, and Xuefeng Liu, and Richard Schlegel, and Anton Wellstein, and Anna T Riegel
January 1982, Experimental eye research,
Copied contents to your clipboard!